Abstract
Retinoids exert pleiotropic effects in various biological processes by binding to their nuclear receptors, the retinoic acid receptors (RARs) and retinoid X receptors (RXRs), to regulate gene transcription. Apo-RARs and RXRs repress target gene expression by recruiting corepressors to the target DNA, triggering chromatin condensation by the action of histone deacetylases present in the corepressor complexes. In contrast, holo-RARs and RXRs recruit coactivators, some known to encode histone acetyl transferases, which trigger histone hyperacetylation, chromatin decondensation, and ultimately gene activation. Receptor interacting protein 140 (RIP140) represents a novel RAR / RXR coregulator that suppresses vitamin A-regulated gene expression in a retinoid- dependent manner. This review addresses the action of different retinoid ligands on gene expression, the molecular mechanisms underlying RAR/RXR-mediated gene regulation, and the unique properties of RIP140 as a novel retinoid hormone-dependent negative coregulator for RAR- and RXR-mediated gene regulation.
Keywords: hormones, retinoids, retinoid receptors, receptor complexes, coactivators, corepressors, gene transcription, histone acetylation, chromatin
Current Medicinal Chemistry
Title: Retinoids and Receptor Interacting Protein 140 (RIP140) in Gene Regulation
Volume: 11 Issue: 12
Author(s): Li-Na Wei
Affiliation:
Keywords: hormones, retinoids, retinoid receptors, receptor complexes, coactivators, corepressors, gene transcription, histone acetylation, chromatin
Abstract: Retinoids exert pleiotropic effects in various biological processes by binding to their nuclear receptors, the retinoic acid receptors (RARs) and retinoid X receptors (RXRs), to regulate gene transcription. Apo-RARs and RXRs repress target gene expression by recruiting corepressors to the target DNA, triggering chromatin condensation by the action of histone deacetylases present in the corepressor complexes. In contrast, holo-RARs and RXRs recruit coactivators, some known to encode histone acetyl transferases, which trigger histone hyperacetylation, chromatin decondensation, and ultimately gene activation. Receptor interacting protein 140 (RIP140) represents a novel RAR / RXR coregulator that suppresses vitamin A-regulated gene expression in a retinoid- dependent manner. This review addresses the action of different retinoid ligands on gene expression, the molecular mechanisms underlying RAR/RXR-mediated gene regulation, and the unique properties of RIP140 as a novel retinoid hormone-dependent negative coregulator for RAR- and RXR-mediated gene regulation.
Export Options
About this article
Cite this article as:
Wei Li-Na, Retinoids and Receptor Interacting Protein 140 (RIP140) in Gene Regulation, Current Medicinal Chemistry 2004; 11 (12) . https://dx.doi.org/10.2174/0929867043365017
DOI https://dx.doi.org/10.2174/0929867043365017 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
Current advances in inherited cardiomyopathy
Describe in detail all novel advances in multimodality imaging related to inherited cardiomyopathy diagnosis and prognosis. Shed light to deeper phenotypic characterization. Acknowledge recent advances in genetics, genomics and precision medicineread more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Role of Serum and Glucocorticoid-Inducible Kinase (SGK)-1 in Senescence: A Novel Molecular Target Against Age-Related Diseases
Current Medicinal Chemistry Epidermal Cell Proliferation in Calorie-Restricted Aging Rats
Current Aging Science Meet Our Editorial Board Member
Current Drug Targets Therapeutic Potential of Voltage Gated Calcium Channels
Mini-Reviews in Medicinal Chemistry Hormonal Therapy for Prostate Cancer: Toward Further Unraveling of Androgen Receptor Function
Anti-Cancer Agents in Medicinal Chemistry G-Coupled Protein Receptors and Breast Cancer Progression: Potential Drug Targets
Mini-Reviews in Medicinal Chemistry The Medical Use of Wheatgrass: Review of the Gap Between Basic and Clinical Applications
Mini-Reviews in Medicinal Chemistry E-MHK-0103 (Mineraxin™): A Novel Nutraceutical with Biological Properties in Menopausal Conditions
Current Drug Metabolism Design of Peptide Imaging Agents for Whole-body and Intraoperative Molecular Imaging
Current Medicinal Chemistry Pharmacologic Modulators of Soluble Guanylate Cyclase/Cyclic Guanosine Monophosphate in the Vascular System - From Bench Top to Bedside
Current Vascular Pharmacology Mechanistic Insights into Aspartame-induced Immune Dysregulation
Current Nutrition & Food Science Label-Free Cell Phenotypic Drug Discovery
Combinatorial Chemistry & High Throughput Screening Medullary Thyroid Cancer: New Targeted Molecular Therapies
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Spinal Microvascular Expression of PV-1 is Associated with Inflammation, Perivascular Astrocyte Loss, and Diminished EC Glucose Transport Potential in Acute SCI
Current Neurovascular Research Recent Updates on Development of Drug Molecules for Human African Trypanosomiasis
Current Topics in Medicinal Chemistry Editorial (Thematic Issue: Novel Therapeutic Strategies for Castration-resistant Prostate Cancer: Update and Future Perspectives)
Clinical Cancer Drugs Physiological Mechanisms of Action of Incretin and Insulin in Regulating Skeletal Muscle Metabolism
Current Diabetes Reviews Hereditary Rickets. How Genetic Alterations Explain the Biochemical and Clinical Phenotypes
Endocrine, Metabolic & Immune Disorders - Drug Targets Triple Treatment with Octreotide, Galanin and Serotonin is a Promising Therapy for Colorectal Cancer
Current Pharmaceutical Design Bitter Gourd (Momordica charantia) is a Cornucopia of Health: A Review of its Credited Antidiabetic, Anti-HIV, and Antitumor Properties
Current Molecular Medicine